Kunshan Asia Aroma Corp. Ltd. (301220) - Total Liabilities

Latest as of June 2025: CN¥682.01 Million CNY ≈ $99.80 Million USD

Based on the latest financial reports, Kunshan Asia Aroma Corp. Ltd. (301220) has total liabilities worth CN¥682.01 Million CNY (≈ $99.80 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Kunshan Asia Aroma Corp. Ltd. (301220) asset resilience to evaluate the company's liquid asset resilience ratio.

Kunshan Asia Aroma Corp. Ltd. - Total Liabilities Trend (2019–2024)

This chart illustrates how Kunshan Asia Aroma Corp. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 301220 current and non-current assets.

Kunshan Asia Aroma Corp. Ltd. Competitors by Total Liabilities

The table below lists competitors of Kunshan Asia Aroma Corp. Ltd. ranked by their total liabilities.

Company Country Total Liabilities
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
China CN¥1.64 Billion
SANTANDER UK 8 5/8% NON-CUM STLG PRF
LSE:SANB
UK GBX251.69 Billion
Kid ASA
OL:KID
Norway Nkr3.27 Billion
Ausgold Ltd
AU:AUC
Australia AU$23.51 Million
Shaanxi Xinghua Chemistry Co Ltd
SHE:002109
China CN¥5.83 Billion
Grenevia S.A.
WAR:GEA
Poland zł1.79 Billion
Shanghai Phoenix Enterprise Group Co Ltd A
SHG:600679
China CN¥1.14 Billion
Nanjing Res In of Surveying Mapping
SHE:300826
China CN¥1.01 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Kunshan Asia Aroma Corp. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 301220 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.47 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.39 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kunshan Asia Aroma Corp. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kunshan Asia Aroma Corp. Ltd. (2019–2024)

The table below shows the annual total liabilities of Kunshan Asia Aroma Corp. Ltd. from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥464.68 Million
≈ $68.00 Million
+77.42%
2023-12-31 CN¥261.90 Million
≈ $38.32 Million
+43.60%
2022-12-31 CN¥182.38 Million
≈ $26.69 Million
-43.14%
2021-12-31 CN¥320.73 Million
≈ $46.93 Million
-4.87%
2020-12-31 CN¥337.16 Million
≈ $49.34 Million
+12.50%
2019-12-31 CN¥299.70 Million
≈ $43.85 Million
--

About Kunshan Asia Aroma Corp. Ltd.

SHE:301220 China Chemicals
Market Cap
$517.34 Million
CN¥3.54 Billion CNY
Market Cap Rank
#12184 Global
#3536 in China
Share Price
CN¥31.35
Change (1 day)
+0.87%
52-Week Range
CN¥25.16 - CN¥48.38
All Time High
CN¥88.60
About

Kunshan Asia Aroma Corp., Ltd. engages in the research and development, production, and sale of spices and food additives in China. It offers natural ingredients, which include Acetaldehyde NAT, Octanal NAT, Nonanal NAT, 2-Methylbutyric Acid NAT, Ethyl 2-Methylbutyrate NAT, Vanillin Ex Eugenol NAT, Vanillin Ex Ferulic Acid NAT, Leaf alcohol NAT, Cis-3-Hexenyl Acetate NAT, Cis-3-Hexenyl Butyrate N… Read more